Mabs | www.gmachineinfo.com | 全球机械文献资源网

OA期刊

ISSN	1942-0862
刊名	Mabs
出版商	Taylor & Francis Inc.
url	https://www.tandfonline.com/loi/kmab20
机构	Taylor & Francis Ltd.

全部

2010	2011	2012	2013	2014	2015
2016	2017	2018	2019	2020	2021
2022	2023	2024	2025

2023, vol.15, no.1

题名

作者

出版年

年卷期

A novel anti-NGF PEGylated Fab’ provides analgesia with lower risk of adverse effects

Yukari Koya;Hirotsugu Tanaka;Eiji Yoshimi;Nobuaki Takeshita;Shuji Morita;Hiroki Morio;Kanako Mori;Hiroshi Fushiki;Masazumi Kamohara;

2023

2023, vol.15, no.1

SpyDisplay: A versatile phage display selection system using SpyTag/SpyCatcher technology

Sarah-Jane Kellmann;Christian Hentrich;Mateusz Putyrski;Hanh Hanuschka;Manuel Cavada;Achim Knappik;Francisco Ylera;

2023

2023, vol.15, no.1

Strategies for clinical dose optimization of T cell-engaging therapies in oncology

Kathryn Ball;Simon J Dovedi;Pavan Vajjah;Alex Phipps;

2023

2023, vol.15, no.1

Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies

Andrew Dippel;Austin Gallegos;Vineela Aleti;Arnita Barnes;Xiaoru Chen;Elizabeth Christian;Jared Delmar;Qun Du;Reza Esfandiary;Erika Farmer;Andrew Garcia;Qing Li;Jia Lin;Weiyi Liu;LeeAnn Machiesky;Neil Mody;Arun Parupudi;Meagan Prophet;Keith Rickert;Kim Rosenthal;Song Ren;Harini Shandilya;Reena Varkey;Kevin Wons;Yuling Wu;Yueh-Ming Loo;Mark T. Esser;Nicole L. Kallewaard;Sarav Rajan;Melissa Damschroder;Weichen Xu;Gilad Kaplan;

2023

2023, vol.15, no.1

Assessing developability early in the discovery process for novel biologics

Monica L. Fernández-Quintero;Anne Ljungars;Franz Waibl;Victor Greiff;Jan Terje Andersen;Torleif T. Gjølberg;Timothy P. Jenkins;Bjørn Gunnar Voldborg;Lise Marie Grav;Sandeep Kumar;Guy Georges;Hubert Kettenberger;Klaus R. Liedl;Peter M. Tessier;John McCafferty;Andreas H. Laustsen;

2023

2023, vol.15, no.1

Characterization of the high-affinity anti-CTLA-4 monoclonal antibody JS007 for immune checkpoint therapy of cancer

Jiawei Guan;Hongchuan Liu;Yan Chai;Jie Yu;Jian Yao;Jing Wang;Zhiwei Pan;Jing Zhang;Yuehua Zhou;Hui Liu;Sheng Yao;Jianxun Qi;Hui Feng;George F. Gao;Qihui Wang;Yi Shi;Shuguang Tan;

2023

2023, vol.15, no.1

High-throughput optofluidic screening of single B cells identifies novel cross-reactive antibodies as inhibitors of uPAR with antibody-dependent effector functions

André Luiz Lourenço;Shih-Wei Chuo;Markus F. Bohn;Byron Hann;Shireen Khan;Neha Yevalekar;Nitin Patel;Teddy Yang;Lina Xu;Dandan Lv;Robert Drakas;Sarah Lively;Charles S. Craik;

2023

2023, vol.15, no.1

eIg-based bispecific T-cell engagers targeting EGFR: Format matters

Lennart Kühl;Annelie K. Schäfer;Sebastian Kraft;Nadine Aschmoneit;Roland E. Kontermann;Oliver Seifert;

2023

2023, vol.15, no.1

HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure

Saw Yen Ow;Eugene A. Kapp;Vesna Tomasetig;Anton Zalewski;Jason Simmonds;Con Panousis;Michael J. Wilson;Andrew D. Nash;Matthias Pelzing;

2023

2023, vol.15, no.1

Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties

Hristo L. Svilenov;Paolo Arosio;Tim Menzen;Peter Tessier;Pietro Sormanni;

2023

2023, vol.15, no.1